Liposomal berberine: is the better absorbed form worth it?
Regular berberine is poorly absorbed, and newer forms that wrap it in fats or phospholipids do get more of it into the blood. But almost none of that evidence is for products actually labelled "liposomal". We found no published human study comparing a liposomal berberine product with regular berberine. The human absorption data come from related forms (a micellar softgel and a phospholipid "phytosome"), in small studies run by the makers or by groups linked to them. And no trial has shown that any of these forms improves blood sugar or cholesterol more than plain berberine HCl, which has the real outcome evidence.
Evidence grade
Question
Grade
Why
Regular berberine lowers glucose, triglycerides and LDL
Moderate
Meta-analyses of many RCTs, mostly from China, some of poor quality
Micellar or phytosome berberine raises blood levels more than regular berberine
Limited
Two small human studies (10 and 12 people), both run by or linked to the makers
Liposomal berberine raises blood levels more than regular berberine in people
No data
Only lab and rat studies
Any enhanced form improves health outcomes more than regular berberine
Not shown
No head to head outcome trials
Enhanced forms are safe
Limited
One 30 day safety study (19 people) and short trials found no safety signals
Key takeaways
At the same 500 mg dose, a micellar berberine softgel (LipoMicel) gave about 6 times more berberine in the blood over 24 hours than a standard capsule in 10 healthy adults (Solnier 2023). The study was run by ISURA, a nonprofit research group, and the owner of the company that makes the product was a co-author.
A phospholipid form (Berberine Phytosome) delivered roughly 10 times more berberine to the blood per milligram of berberine swallowed than berberine chloride in 12 volunteers (Petrangolini 2021). The phytosome tablets held less berberine, so the paper adjusted for dose. All authors worked for Indena, which makes it.
The only human study we found that used liposomal berberine tested it inside a blend with red yeast rice and curcumin, with no control group.
If you choose an enhanced form, compare the actual berberine content per capsule, not the capsule weight, and remember that drug interactions still apply and could be stronger.
As an Amazon Associate, Stacking Years earns from qualifying purchases. This does not affect our rankings.
Only a small fraction of a swallowed dose of berberine reaches the bloodstream. A 2023 review (Murakami), based mostly on rat data, explains why. It dissolves poorly and crosses the gut wall badly, a transporter pumps some of it back out, and enzymes in the gut wall and liver break much of the rest down before it reaches the circulation. Trials of regular berberine have used fairly large doses; those in the 2025 Liu meta-analysis ranged from 300 to 1,500 mg a day. NCCIH describes 200 to 1,000 mg two to three times daily as the range considered safe in clinical use.
Formulation companies try to get around this in several ways:
Form
What it is
Human absorption data
Liposomal
Berberine inside tiny bubbles with a double phospholipid wall
None published that we found; a 2024 rat study of one liposomal form, by the company that makes it, found about 3.4 times higher exposure
Micellar (for example LipoMicel)
Berberine in an emulsified matrix of oils and food grade emulsifiers, in a softgel
One pharmacokinetic study (10 people) and one 30 day safety study (19 people)
Phytosome
Berberine extract dispersed with sunflower lecithin, plus pea protein and grape seed extract in the studied Berberine Phytosome, as a tablet
One pharmacokinetic study (12 people) and trials in women with PCOS
Dihydroberberine (DHB)
A chemically reduced form that converts back to berberine in the body
Labels do not always use these terms precisely. A product sold as "liposomal" may contain a different lipid system, so check what the maker says and whether any human data exist for that exact product.
The human absorption studies
Study
Who
What was compared
Result
Who ran or funded it
Solnier 2023, Pharmaceutics
10 healthy adults, blinded crossover, 7 day washout
500 mg berberine as LipoMicel (two 250 mg softgels) versus one 500 mg standard berberine HCl capsule
Blood exposure over 24 h: 78.2 versus 13.4 ng·h/mL; peak level 15.8 versus 1.67 ng/mL
Most authors work at ISURA, a nonprofit research group; one co-author owns the Factors Group, whose Natural Factors brand made both products
Petrangolini 2021, Evid Based Complement Alternat Med
12 healthy volunteers, randomized crossover
500 mg berberine chloride tablet (452 mg berberine) versus one or two 550 mg Berberine Phytosome tablets (188 mg berberine each)
Around 10 times higher total berberine exposure on a molar basis, meaning after adjusting for the lower berberine content of the phytosome tablets; blood levels significantly higher from 30 minutes (total berberine) and 45 minutes (free berberine)
All authors are employees of Indena, which makes Berberine Phytosome
Two points matter when reading these numbers. First, higher blood levels after one dose show absorption, not benefit. Neither study measured blood sugar or cholesterol. Second, the berberine dose per pill differs between forms, so a product's label claim of "10 times better absorption" does not mean one capsule replaces ten capsules of regular berberine.
What the outcome evidence covers
Regular berberine. A 2025 meta-analysis of placebo controlled trials (Liu, Front Pharmacol) found berberine lowered fasting glucose by about 0.5 mmol/L (about 9 mg/dL), triglycerides by about 0.37 mmol/L, LDL cholesterol by about 0.5 mmol/L and waist size by about 3.3 cm, with side effects no more common than with placebo. NCCIH, describing an earlier 2021 review of berberine for diabetes, notes that most of those studies were in Chinese patients and some were of poor quality. Our berberine guide covers this in depth.
Phytosome berberine. In an open label randomized trial in 130 women with PCOS in Pakistan (Di Pierro 2023), 550 mg twice a day for 90 days led to more women resuming regular periods than in the control group. Metabolic and hormone profiles did not differ significantly between groups at the end. A smaller study in 12 women with PCOS (Rondanelli 2021) had no control group. Neither compared the phytosome with regular berberine.
Micellar berberine. The 30 day study (Ibi 2025, 19 healthy adults, 1,000 mg a day, crossover against placebo) was designed to test safety. It found no significant changes in liver or kidney markers compared with placebo and no reported side effects.
Liposomal berberine. The only human data we found are from Biagi 2018, an 8 week, open label study in 40 people with mild to moderate high cholesterol, with no control group. They took a daily blend of:
Ingredient
Amount per day
Fermented red rice (red yeast rice)
Providing 10 mg monacolin K
Liposomal berberine
47.2 mg
Curcumin
50 mg
LDL cholesterol fell from baseline, but the paper itself notes that monacolins in red yeast rice act like statins, blocking the same enzyme (HMG-CoA reductase), and that most of the effect could be due to the monacolin K. The berberine dose was also a small fraction of what trials of berberine alone use. This study cannot tell you what liposomal berberine does.
Should you pay more for an enhanced form?
An enhanced form may make sense if:
Regular berberine upsets your stomach at the doses that work, and you want to try a lower dose form. No trial has compared side effects directly.
You accept that the evidence is about absorption, not results.
Regular berberine HCl makes more sense if:
You want the form used in the outcome trials.
You want to compare cost per day fairly. Divide the price by the milligrams of actual berberine, not capsule weight.
Drug interactions. Berberine at 300 mg three times a day slowed three liver enzymes (CYP2D6, CYP2C9 and CYP3A4) that clear many drugs (Guo 2012). A form that raises blood levels could make these interactions stronger. See berberine drug interactions.
Low blood sugar. Berberine lowers glucose. If you take diabetes medicine, talk to your doctor first.
Stomach upset. NCCIH lists mild to moderate nausea, diarrhea, bloating and constipation as common side effects.
Pregnancy and breastfeeding. NCCIH says berberine should not be used during pregnancy or breastfeeding, or given to infants.
This page is general information, not medical advice.
Get the free Longevity Supplement Starter Guide
Sign up for the guide and occasional Stacking Years updates. The guide is available on the confirmation screen.
Sources
1. Solnier J, Zhang Y, Kuo YC, Du M, Roh K, Gahler R, et al. Characterization and pharmacokinetic assessment of a new berberine formulation with enhanced absorption in vitro and in human volunteers. Pharmaceutics. 2023;15(11):2567. PMID 38004546
2. Petrangolini G, Corti F, Ronchi M, Arnoldi L, Allegrini P, Riva A. Development of an innovative berberine food-grade formulation with an ameliorated absorption: in vitro evidence confirmed by healthy human volunteers pharmacokinetic study. Evid Based Complement Alternat Med. 2021;2021:7563889. PMID 34904017
3. Ibi A, Chang C, Kuo YC, Zhang Y, Du M, Roh YS, et al. A 30-day randomized crossover human study on the safety and tolerability of a new micellar berberine formulation with improved bioavailability. Metabolites. 2025;15(4):240. PMID 40278369
4. Biagi M, Minoretti P, Bertona M, Emanuele E. Effects of a nutraceutical combination of fermented red rice, liposomal berberine, and curcumin on lipid and inflammatory parameters in patients with mild-to-moderate hypercholesterolemia: an 8-week, open-label, single-arm pilot study. Arch Med Sci Atheroscler Dis. 2018;3:e137-e141. PMID 30775604
5. Sharma VM, Valsaraj TV, Venkataramana Sudeep H, Raj A, Kodimule S, Jacob J. Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology. Eur J Pharm Biopharm. 2024;203:114431. PMID 39094668
6. Di Pierro F, Sultana R, Eusaph AZ, Abrar S, Bugti M, Afridi F, et al. Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Front Pharmacol. 2023;14:1269605. PMID 38074133
7. Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a one-group pretest-post-test explanatory study. Nutrients. 2021;13(10):3665. PMID 34684666
8. Moon JM, Ratliff KM, Hagele AM, Stecker RA, Mumford PW, Kerksick CM. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: a randomized, controlled, crossover pilot trial. Nutrients. 2021;14(1):124. PMID 35010998
9. Chang C, Roh YS, Du M, Kuo YC, Zhang Y, Hardy M, et al. Differences in metabolite profiles of dihydroberberine and micellar berberine in Caco-2 cells and humans: a pilot study. Int J Mol Sci. 2024;25(11):5625. PMID 38891813
10. Liu D, Zhao H, Zhang Y, Hu J, Xu H. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Front Pharmacol. 2025;16:1572197. PMID 40740996
11. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217. PMID 21870106
12. Murakami T, Bodor E, Bodor N. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 1. Physicochemical and pharmacokinetic properties. Expert Opin Drug Metab Toxicol. 2023;19(3):129-137. PMID 37057922
13. National Center for Complementary and Integrative Health. Diabetes and dietary supplements: what you need to know (berberine section). nccih.nih.gov